Cargando…
Peroxisomal 2-Hydroxyacyl-CoA Lyase Is Involved in Endogenous Biosynthesis of Heptadecanoic Acid
Circulating heptadecanoic acid (C17:0) is reported to be a pathology risk/prognosis biomarker and a dietary biomarker. This pathology relationship has been shown to be reliably predictive even when independent of dietary contributions, suggesting that the endogenous biosynthesis of C17:0 is related...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151664/ https://www.ncbi.nlm.nih.gov/pubmed/29027957 http://dx.doi.org/10.3390/molecules22101718 |
_version_ | 1783357203079495680 |
---|---|
author | Jenkins, Benjamin de Schryver, Evelyn Van Veldhoven, Paul P. Koulman, Albert |
author_facet | Jenkins, Benjamin de Schryver, Evelyn Van Veldhoven, Paul P. Koulman, Albert |
author_sort | Jenkins, Benjamin |
collection | PubMed |
description | Circulating heptadecanoic acid (C17:0) is reported to be a pathology risk/prognosis biomarker and a dietary biomarker. This pathology relationship has been shown to be reliably predictive even when independent of dietary contributions, suggesting that the endogenous biosynthesis of C17:0 is related to the pathological aetiology. Little is known about C17:0 biosynthesis, which tissues contribute to the circulating levels, and how C17:0 is related to pathology. Hacl1+/− mice were mated to obtain Hacl1−/− and Hacl1+/+ control mice. At 14 weeks, they were anesthetized for tissue collection and fatty acid analysis. Compared to Hacl1+/+, C15:0 was not significantly affected in any Hacl1−/− tissues. However, the Hacl1−/− plasma and liver C17:0 levels were significantly lower: ~26% and ~22%, respectively. No significant differences were seen in the different adipose tissues. To conclude, Hacl1 plays a significant role in the liver and plasma levels of C17:0, providing evidence it can be endogenously biosynthesized via alpha-oxidation. The strong inverse association of C17:0 with pathology raises the question whether there is a direct link between α-oxidation and these diseases. Currently, there is no clear evidence, warranting further research into the role of α-oxidation in relation to metabolic diseases. |
format | Online Article Text |
id | pubmed-6151664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61516642018-11-13 Peroxisomal 2-Hydroxyacyl-CoA Lyase Is Involved in Endogenous Biosynthesis of Heptadecanoic Acid Jenkins, Benjamin de Schryver, Evelyn Van Veldhoven, Paul P. Koulman, Albert Molecules Article Circulating heptadecanoic acid (C17:0) is reported to be a pathology risk/prognosis biomarker and a dietary biomarker. This pathology relationship has been shown to be reliably predictive even when independent of dietary contributions, suggesting that the endogenous biosynthesis of C17:0 is related to the pathological aetiology. Little is known about C17:0 biosynthesis, which tissues contribute to the circulating levels, and how C17:0 is related to pathology. Hacl1+/− mice were mated to obtain Hacl1−/− and Hacl1+/+ control mice. At 14 weeks, they were anesthetized for tissue collection and fatty acid analysis. Compared to Hacl1+/+, C15:0 was not significantly affected in any Hacl1−/− tissues. However, the Hacl1−/− plasma and liver C17:0 levels were significantly lower: ~26% and ~22%, respectively. No significant differences were seen in the different adipose tissues. To conclude, Hacl1 plays a significant role in the liver and plasma levels of C17:0, providing evidence it can be endogenously biosynthesized via alpha-oxidation. The strong inverse association of C17:0 with pathology raises the question whether there is a direct link between α-oxidation and these diseases. Currently, there is no clear evidence, warranting further research into the role of α-oxidation in relation to metabolic diseases. MDPI 2017-10-13 /pmc/articles/PMC6151664/ /pubmed/29027957 http://dx.doi.org/10.3390/molecules22101718 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jenkins, Benjamin de Schryver, Evelyn Van Veldhoven, Paul P. Koulman, Albert Peroxisomal 2-Hydroxyacyl-CoA Lyase Is Involved in Endogenous Biosynthesis of Heptadecanoic Acid |
title | Peroxisomal 2-Hydroxyacyl-CoA Lyase Is Involved in Endogenous Biosynthesis of Heptadecanoic Acid |
title_full | Peroxisomal 2-Hydroxyacyl-CoA Lyase Is Involved in Endogenous Biosynthesis of Heptadecanoic Acid |
title_fullStr | Peroxisomal 2-Hydroxyacyl-CoA Lyase Is Involved in Endogenous Biosynthesis of Heptadecanoic Acid |
title_full_unstemmed | Peroxisomal 2-Hydroxyacyl-CoA Lyase Is Involved in Endogenous Biosynthesis of Heptadecanoic Acid |
title_short | Peroxisomal 2-Hydroxyacyl-CoA Lyase Is Involved in Endogenous Biosynthesis of Heptadecanoic Acid |
title_sort | peroxisomal 2-hydroxyacyl-coa lyase is involved in endogenous biosynthesis of heptadecanoic acid |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151664/ https://www.ncbi.nlm.nih.gov/pubmed/29027957 http://dx.doi.org/10.3390/molecules22101718 |
work_keys_str_mv | AT jenkinsbenjamin peroxisomal2hydroxyacylcoalyaseisinvolvedinendogenousbiosynthesisofheptadecanoicacid AT deschryverevelyn peroxisomal2hydroxyacylcoalyaseisinvolvedinendogenousbiosynthesisofheptadecanoicacid AT vanveldhovenpaulp peroxisomal2hydroxyacylcoalyaseisinvolvedinendogenousbiosynthesisofheptadecanoicacid AT koulmanalbert peroxisomal2hydroxyacylcoalyaseisinvolvedinendogenousbiosynthesisofheptadecanoicacid |